European Heart Journal, Supplement
-
Publication Venue For
- May Measurement Month: results of 12 national blood pressure screening programmes between 2017 and 2019.. 24:F1-F5. 2022
- Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease.. 24:A19-A31. 2022
- May Measurement Month 2019: results of blood pressure screening from 47 countries.. 23:B1-B5. 2021
- SPECT myocardial perfusion imaging is a strong predictor of sudden cardiac death in patients with coronary artery disease. 11:S52-S52. 2009
- Emerging constructs to maintain safety among patients with acute coronary syndromes requiring surgical coronary revascularization. 10. 2008
- European Heart Journal Supplements: Introduction. 6. 2004
- Gene- and cell-based therapies for cardiovascular diseases: Current status and future directions. 6. 2004
- Risk assessment in cardiovascular disease: From traditional risk factors to genomics. 5. 2003
- Facilitated percutaneous coronary intervention: Results from the SPEED trial. 3. 2001
- Safety issues surrounding use of platelet GP IIb/IIIa antagonists: Reversibility and readministration. 1. 1999
- 183 Small nucleolar RNA SNORD3A: a potential new biomarker and molecular player in heart failure 2021
- Small nucleolar RNA SNORD3A: a potential new biomarker and molecular player in heart failure 2021
- SPECT MPI worsening ischemia and reclassification in CAD patients: a comparison of medical therapy versus revascularization 2011
- Importance of CHARM in relation to other heart failure trials with ARBs 2004